Intra-arterial Albumin Infusion After Endovascular Therapy for Stroke Patients

Más betegség

• Upon admission, the patient's medical history and physical examination revealed manifestations indicative of congestive heart failure (CHF), such as jugular venous distention, the presence of a third heart sound, resting tachycardia at a rate of 100 beats per minute attributable to heart failure, hepatomegaly, and/or lower extremity edema attributable to heart failure or of unknown etiology;
• History of acute myocardial infarction within the preceding 3 months;
• The patient's medical history, electrocardiogram findings upon admission, or physical examination indicated the presence of second- or third-degree heart block or any arrhythmia associated with hemodynamic instability, as determined by the investigator's assessment;
• Computed tomography findings upon admission indicating the presence of any form of hemorrhage;
• Presence of other potentially life-threatening medical conditions;

Laborértékek

• Acute or chronic renal failure with serum creatinine levels exceeding 2.0 mg/dL;
• Previous history of allergic reactions to albumin administration;
• Elevated blood pressure exceeding 185/110 mmHg when investigating the use of albumin administration;
• Individuals with current chronic lung diseases, such as chronic obstructive pulmonary disease, bronchiectasis, or any other lung disorder that significantly impairs daily activities; 12. Individuals with known allergies to albumin.

Egyéb

• Severe anemia characterized by a hematocrit below 32%;
• Pregnancy status;

• Age 18 to 80 years;
• Patients with acute ischemic stroke caused by large vessel occlusion in the intracranial anterior circulation (internal carotid artery, middle cerebral artery M1 and M2 segments) ;
• mTICI score ≥ 2b for the occlude vessel after mechanical thrombectomy;
• Baseline National Institutes of Health Stroke score (NIHSS) ≥ 6;
• Stroke onset to arterial puncture time within 24 hours.